Prader-Willi syndrome-clinical genetics, diagnosis and treatment approaches: an update

MG Butler, JL Miller, JL Forster - Current pediatric reviews, 2019 - ingentaconnect.com
Background: Prader-Willi Syndrome (PWS) is a neurodevelopmental genomic imprinting
disorder with lack of expression of genes inherited from the paternal chromosome 15q11 …

Hypothalamic syndrome

HL Müller, M Tauber, EA Lawson, J Özyurt… - Nature reviews Disease …, 2022 - nature.com
Hypothalamic syndrome (HS) is a rare disorder caused by disease-related and/or treatment-
related injury to the hypothalamus, most commonly associated with rare, non-cancerous …

Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

Current and future state of pharmacological management of pediatric obesity

CK Fox, AS Kelly, JL Reilly, N Theis-Mahon… - International Journal of …, 2024 - nature.com
Pediatric obesity is a highly prevalent chronic disease, which has traditionally been treated
with lifestyle therapy alone. Yet for many youth, lifestyle intervention as a monotherapy is …

Obesity management in Prader–Willi syndrome: Current perspectives

A Crinò, D Fintini, S Bocchini… - … , metabolic syndrome and …, 2018 - Taylor & Francis
Prader–Willi syndrome (PWS) is a complex multisystem disorder due to the absent
expression of the paternally active genes in the PWS critical region on chromosome 15 …

Pediatric obesity: Current concepts

DE Greydanus, M Agana, MK Kamboj, S Shebrain… - Disease-a-Month, 2018 - Elsevier
This discussion reflects on concepts of obesity in children and adolescents in the early 21st
century. It includes reflections on its history, definition, epidemiology, diagnostic …

Treatment of acquired hypothalamic obesity: now and the future

P Dimitri - Frontiers in Endocrinology, 2022 - frontiersin.org
The hypothalamus is the centre of neuroendocrine regulation of energy homeostasis and
appetite. Maldevelopment of, or damage to, the key hypothalamic nuclei disrupts the …

Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review

L van Iersel, KE Brokke, RAH Adan… - Endocrine …, 2019 - academic.oup.com
The development of hypothalamic obesity (HO) following craniopharyngioma (CP) and other
suprasellar tumors leads to reduced patient quality of life. No treatment algorithms are …

Current and emerging therapies for managing hyperphagia and obesity in Prader‐Willi syndrome: A narrative review

Q Tan, CE Orsso, EC Deehan, L Triador… - Obesity …, 2020 - Wiley Online Library
In early childhood, individuals with Prader‐Willi syndrome (PWS) experience excess weight
gain and severe hyperphagia with food compulsivity, which often leads to early onset morbid …

A multidisciplinary approach to the clinical management of Prader–Willi syndrome

J Duis, PJ van Wattum, A Scheimann… - Molecular genetics & …, 2019 - Wiley Online Library
Abstract Background Prader–Willi syndrome (PWS) is a complex neuroendocrine disorder
affecting approximately 1/15,000–1/30,000 people. Unmet medical needs of individuals with …